학술논문
Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment
Document Type
Article
Author
Nowicka, M.; Knapp, A.; Oestergaard, M.Z.; Hilton, L.K.; Scott, D.W.; Sehn, L.H.; Slack, G.W.; Farinha, P.; Morin, R.D.; Ashton-Key, M.; Hargreaves, C.E.; Potter, K.N.; Rose-Zerilli, M.; Strefford, J.C.; Cragg, M.S.; Lee, C.; Foxall, R.; Carter, M.J.; Beers, S.A.; Bolen, C.R.; Klein, C.; Mir, F.; Burton, C.; Klapper, W.; Vitolo, U.; Martelli, M.; Trneny, M.; Rushton, C.K.
Source
In: Blood Advances . (Blood Advances, 10 August 2021, 5(15):2945-2957)
Subject
Language
English
ISSN
24739537
24739529
24739529